Increased estrogen receptor expression has also been observed in vascular smooth muscle cells from both male and female PAH patients [59]; administration of fulvestrant, another estrogen inhibitor used in breast cancer, decreases the expression of estrogen receptors and resulted in a higher 6MWD, increased stroke volume in postmenopausal women with PAH [60]. Here, ESR1 is linked to breast carcinoma.